Exponent Stock Forecast, Price & News

3 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Exponent in the last twelve months. There are currently 1 hold rating and 2 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" Exponent stock.
View analyst ratings for Exponent or view top-rated stocks.

Wall Street analysts have given Exponent a "Buy" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Exponent wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

Exponent saw a decline in short interest in August. As of August 13th, there was short interest totaling 870,700 shares, a decline of 14.6% from the July 29th total of 1,020,000 shares. Based on an average trading volume of 186,800 shares, the short-interest ratio is currently 4.7 days. Currently, 1.7% of the shares of the company are sold short.
View Exponent's Short Interest.

Exponent is scheduled to release its next quarterly earnings announcement on Thursday, November 4th 2021.
View our earnings forecast for Exponent.

Exponent, Inc. (NASDAQ:EXPO) released its earnings results on Thursday, July, 29th. The business services provider reported $0.48 earnings per share for the quarter, topping the Zacks' consensus estimate of $0.42 by $0.06. The business services provider earned $112.47 million during the quarter, compared to analyst estimates of $106.11 million. Exponent had a trailing twelve-month return on equity of 26.17% and a net margin of 21.94%.
View Exponent's earnings history.

Exponent's stock was trading at $75.99 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, EXPO stock has increased by 50.7% and is now trading at $114.50.
View which stocks have been most impacted by COVID-19.

Exponent announced a quarterly dividend on Thursday, July 29th. Stockholders of record on Friday, September 10th will be given a dividend of $0.20 per share on Friday, September 24th. This represents a $0.80 dividend on an annualized basis and a yield of 0.70%. The ex-dividend date of this dividend is Thursday, September 9th.
View Exponent's dividend history.

Exponent pays an annual dividend of $0.80 per share and currently has a dividend yield of 0.70%. The dividend payout ratio of Exponent is 51.61%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, Exponent will have a dividend payout ratio of 41.67% next year. This indicates that Exponent will be able to sustain or increase its dividend.
View Exponent's dividend history.

Exponent shares split on Thursday, June 7th 2018. The 2-1 split was announced on Tuesday, May 15th 2018. The newly created shares were issued to shareholders after the closing bell on Wednesday, June 6th 2018. An investor that had 100 shares of Exponent stock prior to the split would have 200 shares after the split.

3 Wall Street analysts have issued 1-year price objectives for Exponent's shares. Their forecasts range from $118.00 to $118.00. On average, they expect Exponent's stock price to reach $118.00 in the next year. This suggests a possible upside of 3.1% from the stock's current price.
View analysts' price targets for Exponent or view top-rated stocks among Wall Street analysts.

15 employees have rated Exponent CEO Catherine Corrigan on Glassdoor.com. Catherine Corrigan has an approval rating of 84% among Exponent's employees.

Some companies that are related to Exponent include Verisk Analytics (VRSK), Equifax (EFX), Dun & Bradstreet (DNB), Nielsen (NLSN), FTI Consulting (FCN), CBIZ (CBZ), ICF International (ICFI), Huron Consulting Group (HURN), CRA International (CRAI), VSE (VSEC), Franklin Covey (FC), Acacia Research (ACTG), Mistras Group (MG) and Odyssey Marine Exploration (OMEX).
View all of EXPO's competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Exponent investors own include AbbVie (ABBV), Pfizer (PFE), Abbott Laboratories (ABT), Energy Transfer (ET), Ford Motor (F), Micron Technology (MU), AT&T (T), UnitedHealth Group (UNH), Visa (V) and Adobe (ADBE).

Exponent trades on the NASDAQ under the ticker symbol "EXPO."

Exponent's stock is owned by a number of retail and institutional investors. Top institutional investors include BlackRock Inc. (15.00%), Vanguard Group Inc. (10.80%), Neuberger Berman Group LLC (6.23%), Kayne Anderson Rudnick Investment Management LLC (4.37%), Conestoga Capital Advisors LLC (3.83%) and State Street Corp (3.10%). Company insiders that own Exponent stock include Bradley A James, Carol Lindstrom, Harri Kytomaa, John Pye, Maureen T F Reitman, Paul R Johnston, Paul R Johnston, Richard L Schlenker Jr, Richard Reiss, Sally Shepard and Steven J Murray.
View institutional ownership trends for Exponent.

EXPO stock was sold by a variety of institutional investors in the last quarter, including BlackRock Inc., Wells Fargo & Company MN, AXA S.A., Neuberger Berman Group LLC, Deutsche Bank AG, Canada Pension Plan Investment Board, JPMorgan Chase & Co., and Copeland Capital Management LLC. Company insiders that have sold Exponent company stock in the last year include Bradley A James, Carol Lindstrom, Harri Kytomaa, John Pye, Maureen T F Reitman, Paul R Johnston, Richard L Schlenker Jr, and Steven J Murray.
View insider buying and selling activity for Exponent or view top insider-selling stocks.

EXPO stock was acquired by a variety of institutional investors in the last quarter, including Kayne Anderson Rudnick Investment Management LLC, Millennium Management LLC, Renaissance Technologies LLC, Ardevora Asset Management LLP, Bank of Montreal Can, The Manufacturers Life Insurance Company , State Street Corp, and Vanguard Group Inc..
View insider buying and selling activity for Exponent or or view top insider-buying stocks.

Shares of EXPO can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of EXPO stock can currently be purchased for approximately $114.50.

Exponent has a market capitalization of $5.96 billion and generates $399.90 million in revenue each year. The business services provider earns $82.55 million in net income (profit) each year or $1.55 on an earnings per share basis.

Exponent employs 1,168 workers across the globe.

The following companies are subsidiares of Exponent: Dennis Publishing.

Exponent was founded in 1967.

The official website for Exponent is www.exponent.com.

Exponent is headquartered at 149 COMMONWEALTH DRIVE, MENLO PARK CA, 94025.

Exponent's mailing address is 149 COMMONWEALTH DRIVE, MENLO PARK CA, 94025. The business services provider can be reached via phone at (650) 326-9400 or via email at [email protected].